|
M
Mon
|
T
Tue
|
W
Wed
|
T
Thu
|
F
Fri
|
S
Sat
|
S
Sun
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
1 event,
-
The Medical Device Innovation Consortium (MDIC) will host a workshop on 3 Feb 2020 to explore key considerations for using real world data to help support in vitro diagnostic (IVD) products available under FDA’s emergency use authorization (EUA) to advance to full marketing status. A roadmap for diagnostic evaluations during emergencies would help enable stakeholders |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
A U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity will be held Feb 25-26, 2020 at the NIAID Conference Center in Rockville, Md. This meeting, sponsored by the NIH Chemical Countermeasures Research Program (CCRP) and organized in collaboration with the National Eye Institute (HHS/NIH/NEI) and |
2 events,
A planning committee of the National Academies of Sciences, Engineering, and Medicine will conduct a one day workshop on Feb 26, 2020 to bring together stakeholders to discuss potential ethical issues that may arise from new and emerging trends in biomedical research (including behavioral and social research) and society. The workshop will identify a range |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
